Sunday, November 22, 2026

Overseas acquisitions: Indian drugmakers shop for deals abroad as they move away from generics

Date:

“In terms of outbound deals in pharma, with the top 10-15 players, certainly we are seeing an increase in appetite,” said Subhakanta Bal, managing director and head of healthcare and consumer (India) at Rothschild & Co. “You could say that it is an evolution for the Indian pharma sector, where larger companies are increasingly looking at doing outbound deals.”

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

CLSA sees better US-India trade outlook; expects Fed and RBI to raise rates in December

The US is likely to push ahead with trade...

‘Trump has cost us’: After midterm losses, MAGA asks if it’s over

As Republicans faced a nationwide drubbing in Tuesday’s midterm...

Prashant Jain sees 12-15% annual returns from Indian equities over 3-5 years

Question We've had a very painful period for the equity...

Raamdeo Agrawal sees FIIs return as earnings improve and valuations turn attractive

Question Looking at the valuation compression across the market, are...